173 related articles for article (PubMed ID: 38075039)
1. Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm.
Jia H; Qu W; Cai X; Li M; Qian Y; Jiang Z; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1286947. PubMed ID: 38075039
[TBL] [Abstract][Full Text] [Related]
2. Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy.
Vera L; Gay S; Campomenosi C; Paolino S; Pera G; Monti E; Mortara L; Seriolo B; Giusti M
Endokrynol Pol; 2016; 67(4):350-8. PubMed ID: 27387240
[TBL] [Abstract][Full Text] [Related]
3. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
5. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
[TBL] [Abstract][Full Text] [Related]
6. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
8. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX.
Kälvesten J; Lui LY; Brismar T; Cummings S
Bone; 2016 May; 86():30-5. PubMed ID: 26921822
[TBL] [Abstract][Full Text] [Related]
9. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
[TBL] [Abstract][Full Text] [Related]
11. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
[TBL] [Abstract][Full Text] [Related]
12. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of FRAX in the assessment of fracture risk in patients with rheumatic disease in three medical center].
Ye B; Huang YH; Zhang L; Tian XL; Zhang Q; Lu MH; Xu PH; Guo J; Kong XY; Zhou HQ
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(42):3345-3349. PubMed ID: 31715673
[No Abstract] [Full Text] [Related]
14. Comparison of screening tools for optimizing fracture prevention in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Oct; 15(1):170. PubMed ID: 33111193
[TBL] [Abstract][Full Text] [Related]
15. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
[TBL] [Abstract][Full Text] [Related]
16. Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy.
Ran B; Wei F; Gong J; Xu H
Front Endocrinol (Lausanne); 2022; 13():1004962. PubMed ID: 36313757
[TBL] [Abstract][Full Text] [Related]
17. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
[TBL] [Abstract][Full Text] [Related]
18. FRAX tool in type 2 diabetic subjects: the use of HbA
Valentini A; Cianfarani MA; De Meo L; Morabito P; Romanello D; Tarantino U; Federici M; Bertoli A
Acta Diabetol; 2018 Oct; 55(10):1043-1050. PubMed ID: 29980834
[TBL] [Abstract][Full Text] [Related]
19. An optimal intervention threshold of FRAX in postmenopausal Thai women.
Sribenjalak D; Charoensri S; Pongchaiyakul C
Arch Osteoporos; 2022 Jan; 17(1):21. PubMed ID: 35072805
[TBL] [Abstract][Full Text] [Related]
20. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
